Close
CDMO Safety Testing 2026
Novotech

Thermo Fisher Scientific Completes Sales of Athena Diagnostics and Lancaster Laboratories

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Incyte Expands Haematology Portfolio with Vega Acquisition

Incyte has agreed to acquire Vega Therapeutics, a subsidiary...

GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition

GSK has agreed to acquire Nuvalent in a transaction...

Firefly Bio Acquisition Strengthens J&J Cancer Pipeline

Johnson & Johnson (J&J) has entered into a definitive...
- Advertisement -

Thermo Fisher Scientific Inc., the world leader in serving science, has completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.

Athena Diagnostics has been sold to Quest Diagnostics for $740 million. Based in Worcester, Mass., Athena Diagnostics is a leading reference laboratory that provides comprehensive diagnostic testing for neurological and other diseases. The business had approximately $110 million in revenues for full year 2010, has approximately 300 employees and was part of Thermo Fisher’s specialty diagnostics business within its Analytical Technologies Segment.

ย 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Incyte Expands Haematology Portfolio with Vega Acquisition

Incyte has agreed to acquire Vega Therapeutics, a subsidiary...

GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition

GSK has agreed to acquire Nuvalent in a transaction...

Firefly Bio Acquisition Strengthens J&J Cancer Pipeline

Johnson & Johnson (J&J) has entered into a definitive...

Daewoong and Chime Biologics Partner for Biosimilar Push

Chime Biologics and Daewoong Pharmaceutical have entered into a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป